Clinical Trial Update: Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Pilot Phase 1 trial of DAPAglifozin as an add-on to closed-loop insulin control in Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• DAPAglifozin (dapagliflozin)

Snippet

Sponsor: Kinderkrankenhaus auf der Bult | Conditions: Type1diabetes | Phase 1 | Status: COMPLETED